CareFusion plans to buy Medegen for $225 million

04/5/2010 | Reuters

CareFusion agreed to pay $225 million to acquire Medegen, a maker of intravenous drug-delivery systems and needle-free access valves. CareFusion said the acquisition, which is expected to conclude by the end of June, is in line with its objective to purchase firms and technology that will boost its divisions including infusion and respiratory.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA